Review



human bladder carcinoma cell line j82  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    ATCC human bladder carcinoma cell line j82
    Rationale for selecting CDKN1A /p21 as a therapeutic target in bladder cancer and validation of p21 mRNA expression. (A) Pan‐cancer analysis of CDKN1A alteration frequencies based on TCGA datasets. The analysis was performed using the TIMER3 web server. (B) CDKN1A mRNA expression in bladder cancer and normal bladder tissues, shown as log2(TPM + 1), where TPM denotes transcripts per million. Data were analyzed using the TIMER3 web server. (C) Representative p21 immunohistochemical staining images from a bladder cancer tissue microarray stratified by pathological stage (Tis, T1, T2, T3, and T4). Scale bars, 200 μm. (D) Quantification of p21 H‐scores in Tis, T1, T2, T3, and T4 lesions. Compared with Tis lesions, T1, T2, T3, and T4 tumors showed significantly lower p21 H‐scores. Data are presented as mean ± SD. * p < 0.05, ** p < 0.01 (one‐way ANOVA). (E) Western blot analysis of basal and p21 mRNA‐induced p21 protein expression in T24 and <t>J82</t> bladder cancer cells. Basal p21 protein levels were very low in both cell lines, whereas transfection of p21 mRNA led to robust p21 expression. For p21 blots, both short‐exposure (se) and long‐exposure (le) images are shown. β‐Actin serves as a loading control. (F) Immunofluorescence analysis of EGFP‐HA and p21‐HA expression in T24 and J82 cells using an anti‐HA antibody. Nuclei were stained with DAPI. The p21‐HA signal was predominantly localized to the nucleus, whereas EGFP showed diffuse cytoplasmic distribution. Scale bars, 20 μm.
    Human Bladder Carcinoma Cell Line J82, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 803 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+bladder+carcinoma+cell+lines/pmc13181305-45-1-19?v=ATCC
    Average 96 stars, based on 803 article reviews
    human bladder carcinoma cell line j82 - by Bioz Stars, 2026-07
    96/100 stars

    Images

    1) Product Images from "Intravesical Delivery of P21 mRNA –Loaded Lipid Nanoparticles as a Tumor Suppressor Replacement Therapy for Bladder Cancer"

    Article Title: Intravesical Delivery of P21 mRNA –Loaded Lipid Nanoparticles as a Tumor Suppressor Replacement Therapy for Bladder Cancer

    Journal: The FASEB Journal

    doi: 10.1096/fj.202600049R

    Rationale for selecting CDKN1A /p21 as a therapeutic target in bladder cancer and validation of p21 mRNA expression. (A) Pan‐cancer analysis of CDKN1A alteration frequencies based on TCGA datasets. The analysis was performed using the TIMER3 web server. (B) CDKN1A mRNA expression in bladder cancer and normal bladder tissues, shown as log2(TPM + 1), where TPM denotes transcripts per million. Data were analyzed using the TIMER3 web server. (C) Representative p21 immunohistochemical staining images from a bladder cancer tissue microarray stratified by pathological stage (Tis, T1, T2, T3, and T4). Scale bars, 200 μm. (D) Quantification of p21 H‐scores in Tis, T1, T2, T3, and T4 lesions. Compared with Tis lesions, T1, T2, T3, and T4 tumors showed significantly lower p21 H‐scores. Data are presented as mean ± SD. * p < 0.05, ** p < 0.01 (one‐way ANOVA). (E) Western blot analysis of basal and p21 mRNA‐induced p21 protein expression in T24 and J82 bladder cancer cells. Basal p21 protein levels were very low in both cell lines, whereas transfection of p21 mRNA led to robust p21 expression. For p21 blots, both short‐exposure (se) and long‐exposure (le) images are shown. β‐Actin serves as a loading control. (F) Immunofluorescence analysis of EGFP‐HA and p21‐HA expression in T24 and J82 cells using an anti‐HA antibody. Nuclei were stained with DAPI. The p21‐HA signal was predominantly localized to the nucleus, whereas EGFP showed diffuse cytoplasmic distribution. Scale bars, 20 μm.
    Figure Legend Snippet: Rationale for selecting CDKN1A /p21 as a therapeutic target in bladder cancer and validation of p21 mRNA expression. (A) Pan‐cancer analysis of CDKN1A alteration frequencies based on TCGA datasets. The analysis was performed using the TIMER3 web server. (B) CDKN1A mRNA expression in bladder cancer and normal bladder tissues, shown as log2(TPM + 1), where TPM denotes transcripts per million. Data were analyzed using the TIMER3 web server. (C) Representative p21 immunohistochemical staining images from a bladder cancer tissue microarray stratified by pathological stage (Tis, T1, T2, T3, and T4). Scale bars, 200 μm. (D) Quantification of p21 H‐scores in Tis, T1, T2, T3, and T4 lesions. Compared with Tis lesions, T1, T2, T3, and T4 tumors showed significantly lower p21 H‐scores. Data are presented as mean ± SD. * p < 0.05, ** p < 0.01 (one‐way ANOVA). (E) Western blot analysis of basal and p21 mRNA‐induced p21 protein expression in T24 and J82 bladder cancer cells. Basal p21 protein levels were very low in both cell lines, whereas transfection of p21 mRNA led to robust p21 expression. For p21 blots, both short‐exposure (se) and long‐exposure (le) images are shown. β‐Actin serves as a loading control. (F) Immunofluorescence analysis of EGFP‐HA and p21‐HA expression in T24 and J82 cells using an anti‐HA antibody. Nuclei were stained with DAPI. The p21‐HA signal was predominantly localized to the nucleus, whereas EGFP showed diffuse cytoplasmic distribution. Scale bars, 20 μm.

    Techniques Used: Biomarker Discovery, Expressing, Immunohistochemical staining, Staining, Microarray, Western Blot, Transfection, Control, Immunofluorescence



    Similar Products

    96
    ATCC human bladder carcinoma cell line j82
    Rationale for selecting CDKN1A /p21 as a therapeutic target in bladder cancer and validation of p21 mRNA expression. (A) Pan‐cancer analysis of CDKN1A alteration frequencies based on TCGA datasets. The analysis was performed using the TIMER3 web server. (B) CDKN1A mRNA expression in bladder cancer and normal bladder tissues, shown as log2(TPM + 1), where TPM denotes transcripts per million. Data were analyzed using the TIMER3 web server. (C) Representative p21 immunohistochemical staining images from a bladder cancer tissue microarray stratified by pathological stage (Tis, T1, T2, T3, and T4). Scale bars, 200 μm. (D) Quantification of p21 H‐scores in Tis, T1, T2, T3, and T4 lesions. Compared with Tis lesions, T1, T2, T3, and T4 tumors showed significantly lower p21 H‐scores. Data are presented as mean ± SD. * p < 0.05, ** p < 0.01 (one‐way ANOVA). (E) Western blot analysis of basal and p21 mRNA‐induced p21 protein expression in T24 and <t>J82</t> bladder cancer cells. Basal p21 protein levels were very low in both cell lines, whereas transfection of p21 mRNA led to robust p21 expression. For p21 blots, both short‐exposure (se) and long‐exposure (le) images are shown. β‐Actin serves as a loading control. (F) Immunofluorescence analysis of EGFP‐HA and p21‐HA expression in T24 and J82 cells using an anti‐HA antibody. Nuclei were stained with DAPI. The p21‐HA signal was predominantly localized to the nucleus, whereas EGFP showed diffuse cytoplasmic distribution. Scale bars, 20 μm.
    Human Bladder Carcinoma Cell Line J82, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+bladder+carcinoma+cell+lines/pmc13181305-45-1-19?v=ATCC
    Average 96 stars, based on 1 article reviews
    human bladder carcinoma cell line j82 - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    98
    ATCC human bladder carcinoma cell lines t24
    Rationale for selecting CDKN1A /p21 as a therapeutic target in bladder cancer and validation of p21 mRNA expression. (A) Pan‐cancer analysis of CDKN1A alteration frequencies based on TCGA datasets. The analysis was performed using the TIMER3 web server. (B) CDKN1A mRNA expression in bladder cancer and normal bladder tissues, shown as log2(TPM + 1), where TPM denotes transcripts per million. Data were analyzed using the TIMER3 web server. (C) Representative p21 immunohistochemical staining images from a bladder cancer tissue microarray stratified by pathological stage (Tis, T1, T2, T3, and T4). Scale bars, 200 μm. (D) Quantification of p21 H‐scores in Tis, T1, T2, T3, and T4 lesions. Compared with Tis lesions, T1, T2, T3, and T4 tumors showed significantly lower p21 H‐scores. Data are presented as mean ± SD. * p < 0.05, ** p < 0.01 (one‐way ANOVA). (E) Western blot analysis of basal and p21 mRNA‐induced p21 protein expression in T24 and <t>J82</t> bladder cancer cells. Basal p21 protein levels were very low in both cell lines, whereas transfection of p21 mRNA led to robust p21 expression. For p21 blots, both short‐exposure (se) and long‐exposure (le) images are shown. β‐Actin serves as a loading control. (F) Immunofluorescence analysis of EGFP‐HA and p21‐HA expression in T24 and J82 cells using an anti‐HA antibody. Nuclei were stained with DAPI. The p21‐HA signal was predominantly localized to the nucleus, whereas EGFP showed diffuse cytoplasmic distribution. Scale bars, 20 μm.
    Human Bladder Carcinoma Cell Lines T24, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+bladder+carcinoma+cell+lines/pm41934550-40-1-12?v=ATCC
    Average 98 stars, based on 1 article reviews
    human bladder carcinoma cell lines t24 - by Bioz Stars, 2026-07
    98/100 stars
      Buy from Supplier

    86
    Procell Inc human bladder carcinoma cell line 5637
    Rationale for selecting CDKN1A /p21 as a therapeutic target in bladder cancer and validation of p21 mRNA expression. (A) Pan‐cancer analysis of CDKN1A alteration frequencies based on TCGA datasets. The analysis was performed using the TIMER3 web server. (B) CDKN1A mRNA expression in bladder cancer and normal bladder tissues, shown as log2(TPM + 1), where TPM denotes transcripts per million. Data were analyzed using the TIMER3 web server. (C) Representative p21 immunohistochemical staining images from a bladder cancer tissue microarray stratified by pathological stage (Tis, T1, T2, T3, and T4). Scale bars, 200 μm. (D) Quantification of p21 H‐scores in Tis, T1, T2, T3, and T4 lesions. Compared with Tis lesions, T1, T2, T3, and T4 tumors showed significantly lower p21 H‐scores. Data are presented as mean ± SD. * p < 0.05, ** p < 0.01 (one‐way ANOVA). (E) Western blot analysis of basal and p21 mRNA‐induced p21 protein expression in T24 and <t>J82</t> bladder cancer cells. Basal p21 protein levels were very low in both cell lines, whereas transfection of p21 mRNA led to robust p21 expression. For p21 blots, both short‐exposure (se) and long‐exposure (le) images are shown. β‐Actin serves as a loading control. (F) Immunofluorescence analysis of EGFP‐HA and p21‐HA expression in T24 and J82 cells using an anti‐HA antibody. Nuclei were stained with DAPI. The p21‐HA signal was predominantly localized to the nucleus, whereas EGFP showed diffuse cytoplasmic distribution. Scale bars, 20 μm.
    Human Bladder Carcinoma Cell Line 5637, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+bladder+carcinoma+cell+lines/10__1097_slash_js9__0000000000005112-185-1-10?v=Procell+Inc
    Average 86 stars, based on 1 article reviews
    human bladder carcinoma cell line 5637 - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    97
    ATCC human bladder carcinoma cell line 5637
    Rationale for selecting CDKN1A /p21 as a therapeutic target in bladder cancer and validation of p21 mRNA expression. (A) Pan‐cancer analysis of CDKN1A alteration frequencies based on TCGA datasets. The analysis was performed using the TIMER3 web server. (B) CDKN1A mRNA expression in bladder cancer and normal bladder tissues, shown as log2(TPM + 1), where TPM denotes transcripts per million. Data were analyzed using the TIMER3 web server. (C) Representative p21 immunohistochemical staining images from a bladder cancer tissue microarray stratified by pathological stage (Tis, T1, T2, T3, and T4). Scale bars, 200 μm. (D) Quantification of p21 H‐scores in Tis, T1, T2, T3, and T4 lesions. Compared with Tis lesions, T1, T2, T3, and T4 tumors showed significantly lower p21 H‐scores. Data are presented as mean ± SD. * p < 0.05, ** p < 0.01 (one‐way ANOVA). (E) Western blot analysis of basal and p21 mRNA‐induced p21 protein expression in T24 and <t>J82</t> bladder cancer cells. Basal p21 protein levels were very low in both cell lines, whereas transfection of p21 mRNA led to robust p21 expression. For p21 blots, both short‐exposure (se) and long‐exposure (le) images are shown. β‐Actin serves as a loading control. (F) Immunofluorescence analysis of EGFP‐HA and p21‐HA expression in T24 and J82 cells using an anti‐HA antibody. Nuclei were stained with DAPI. The p21‐HA signal was predominantly localized to the nucleus, whereas EGFP showed diffuse cytoplasmic distribution. Scale bars, 20 μm.
    Human Bladder Carcinoma Cell Line 5637, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+bladder+carcinoma+cell+lines/10__1016_slash_j__molstruc__2026__145577-187-1-11?v=ATCC
    Average 97 stars, based on 1 article reviews
    human bladder carcinoma cell line 5637 - by Bioz Stars, 2026-07
    97/100 stars
      Buy from Supplier

    96
    ATCC human bladder carcinoma tccsup cell line
    Rationale for selecting CDKN1A /p21 as a therapeutic target in bladder cancer and validation of p21 mRNA expression. (A) Pan‐cancer analysis of CDKN1A alteration frequencies based on TCGA datasets. The analysis was performed using the TIMER3 web server. (B) CDKN1A mRNA expression in bladder cancer and normal bladder tissues, shown as log2(TPM + 1), where TPM denotes transcripts per million. Data were analyzed using the TIMER3 web server. (C) Representative p21 immunohistochemical staining images from a bladder cancer tissue microarray stratified by pathological stage (Tis, T1, T2, T3, and T4). Scale bars, 200 μm. (D) Quantification of p21 H‐scores in Tis, T1, T2, T3, and T4 lesions. Compared with Tis lesions, T1, T2, T3, and T4 tumors showed significantly lower p21 H‐scores. Data are presented as mean ± SD. * p < 0.05, ** p < 0.01 (one‐way ANOVA). (E) Western blot analysis of basal and p21 mRNA‐induced p21 protein expression in T24 and <t>J82</t> bladder cancer cells. Basal p21 protein levels were very low in both cell lines, whereas transfection of p21 mRNA led to robust p21 expression. For p21 blots, both short‐exposure (se) and long‐exposure (le) images are shown. β‐Actin serves as a loading control. (F) Immunofluorescence analysis of EGFP‐HA and p21‐HA expression in T24 and J82 cells using an anti‐HA antibody. Nuclei were stained with DAPI. The p21‐HA signal was predominantly localized to the nucleus, whereas EGFP showed diffuse cytoplasmic distribution. Scale bars, 20 μm.
    Human Bladder Carcinoma Tccsup Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+bladder+carcinoma+cell+lines/pmc12654336-33-0-6?v=ATCC
    Average 96 stars, based on 1 article reviews
    human bladder carcinoma tccsup cell line - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    ATCC rt4 human bladder carcinoma cell lines
    Rationale for selecting CDKN1A /p21 as a therapeutic target in bladder cancer and validation of p21 mRNA expression. (A) Pan‐cancer analysis of CDKN1A alteration frequencies based on TCGA datasets. The analysis was performed using the TIMER3 web server. (B) CDKN1A mRNA expression in bladder cancer and normal bladder tissues, shown as log2(TPM + 1), where TPM denotes transcripts per million. Data were analyzed using the TIMER3 web server. (C) Representative p21 immunohistochemical staining images from a bladder cancer tissue microarray stratified by pathological stage (Tis, T1, T2, T3, and T4). Scale bars, 200 μm. (D) Quantification of p21 H‐scores in Tis, T1, T2, T3, and T4 lesions. Compared with Tis lesions, T1, T2, T3, and T4 tumors showed significantly lower p21 H‐scores. Data are presented as mean ± SD. * p < 0.05, ** p < 0.01 (one‐way ANOVA). (E) Western blot analysis of basal and p21 mRNA‐induced p21 protein expression in T24 and <t>J82</t> bladder cancer cells. Basal p21 protein levels were very low in both cell lines, whereas transfection of p21 mRNA led to robust p21 expression. For p21 blots, both short‐exposure (se) and long‐exposure (le) images are shown. β‐Actin serves as a loading control. (F) Immunofluorescence analysis of EGFP‐HA and p21‐HA expression in T24 and J82 cells using an anti‐HA antibody. Nuclei were stained with DAPI. The p21‐HA signal was predominantly localized to the nucleus, whereas EGFP showed diffuse cytoplasmic distribution. Scale bars, 20 μm.
    Rt4 Human Bladder Carcinoma Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+bladder+carcinoma+cell+lines/pm40516199-87-2-12?v=ATCC
    Average 96 stars, based on 1 article reviews
    rt4 human bladder carcinoma cell lines - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    98
    ATCC human t24 bladder carcinoma cell line
    Effect of curcumin on cell proliferation and mean of IC 50 values of K9TCC-PU AXA ( A ), AXC ( B ), and SH ( C ) canine and human <t>T24</t> ( D ) cell lines after 72 h of incubation. *** p < 0.001 and **** p < 0.0001. Vertical intermittent lines show IC 50 dose and colored dots represent the drug dose (ng/mL).
    Human T24 Bladder Carcinoma Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+bladder+carcinoma+cell+lines/pmc12153849-70-1-7?v=ATCC
    Average 98 stars, based on 1 article reviews
    human t24 bladder carcinoma cell line - by Bioz Stars, 2026-07
    98/100 stars
      Buy from Supplier

    90
    BioResource International Inc human bladder carcinoma t24 cell line
    Effect of curcumin on cell proliferation and mean of IC 50 values of K9TCC-PU AXA ( A ), AXC ( B ), and SH ( C ) canine and human <t>T24</t> ( D ) cell lines after 72 h of incubation. *** p < 0.001 and **** p < 0.0001. Vertical intermittent lines show IC 50 dose and colored dots represent the drug dose (ng/mL).
    Human Bladder Carcinoma T24 Cell Line, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+bladder+carcinoma+cell+lines/pm39955573-36-1-18?v=BioResource+International+Inc
    Average 90 stars, based on 1 article reviews
    human bladder carcinoma t24 cell line - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    98
    ATCC human bladder transitional cell carcinoma cell lines
    Effect of curcumin on cell proliferation and mean of IC 50 values of K9TCC-PU AXA ( A ), AXC ( B ), and SH ( C ) canine and human <t>T24</t> ( D ) cell lines after 72 h of incubation. *** p < 0.001 and **** p < 0.0001. Vertical intermittent lines show IC 50 dose and colored dots represent the drug dose (ng/mL).
    Human Bladder Transitional Cell Carcinoma Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+bladder+carcinoma+cell+lines/pmc12170997-23-0-13?v=ATCC
    Average 98 stars, based on 1 article reviews
    human bladder transitional cell carcinoma cell lines - by Bioz Stars, 2026-07
    98/100 stars
      Buy from Supplier

    Image Search Results


    Rationale for selecting CDKN1A /p21 as a therapeutic target in bladder cancer and validation of p21 mRNA expression. (A) Pan‐cancer analysis of CDKN1A alteration frequencies based on TCGA datasets. The analysis was performed using the TIMER3 web server. (B) CDKN1A mRNA expression in bladder cancer and normal bladder tissues, shown as log2(TPM + 1), where TPM denotes transcripts per million. Data were analyzed using the TIMER3 web server. (C) Representative p21 immunohistochemical staining images from a bladder cancer tissue microarray stratified by pathological stage (Tis, T1, T2, T3, and T4). Scale bars, 200 μm. (D) Quantification of p21 H‐scores in Tis, T1, T2, T3, and T4 lesions. Compared with Tis lesions, T1, T2, T3, and T4 tumors showed significantly lower p21 H‐scores. Data are presented as mean ± SD. * p < 0.05, ** p < 0.01 (one‐way ANOVA). (E) Western blot analysis of basal and p21 mRNA‐induced p21 protein expression in T24 and J82 bladder cancer cells. Basal p21 protein levels were very low in both cell lines, whereas transfection of p21 mRNA led to robust p21 expression. For p21 blots, both short‐exposure (se) and long‐exposure (le) images are shown. β‐Actin serves as a loading control. (F) Immunofluorescence analysis of EGFP‐HA and p21‐HA expression in T24 and J82 cells using an anti‐HA antibody. Nuclei were stained with DAPI. The p21‐HA signal was predominantly localized to the nucleus, whereas EGFP showed diffuse cytoplasmic distribution. Scale bars, 20 μm.

    Journal: The FASEB Journal

    Article Title: Intravesical Delivery of P21 mRNA –Loaded Lipid Nanoparticles as a Tumor Suppressor Replacement Therapy for Bladder Cancer

    doi: 10.1096/fj.202600049R

    Figure Lengend Snippet: Rationale for selecting CDKN1A /p21 as a therapeutic target in bladder cancer and validation of p21 mRNA expression. (A) Pan‐cancer analysis of CDKN1A alteration frequencies based on TCGA datasets. The analysis was performed using the TIMER3 web server. (B) CDKN1A mRNA expression in bladder cancer and normal bladder tissues, shown as log2(TPM + 1), where TPM denotes transcripts per million. Data were analyzed using the TIMER3 web server. (C) Representative p21 immunohistochemical staining images from a bladder cancer tissue microarray stratified by pathological stage (Tis, T1, T2, T3, and T4). Scale bars, 200 μm. (D) Quantification of p21 H‐scores in Tis, T1, T2, T3, and T4 lesions. Compared with Tis lesions, T1, T2, T3, and T4 tumors showed significantly lower p21 H‐scores. Data are presented as mean ± SD. * p < 0.05, ** p < 0.01 (one‐way ANOVA). (E) Western blot analysis of basal and p21 mRNA‐induced p21 protein expression in T24 and J82 bladder cancer cells. Basal p21 protein levels were very low in both cell lines, whereas transfection of p21 mRNA led to robust p21 expression. For p21 blots, both short‐exposure (se) and long‐exposure (le) images are shown. β‐Actin serves as a loading control. (F) Immunofluorescence analysis of EGFP‐HA and p21‐HA expression in T24 and J82 cells using an anti‐HA antibody. Nuclei were stained with DAPI. The p21‐HA signal was predominantly localized to the nucleus, whereas EGFP showed diffuse cytoplasmic distribution. Scale bars, 20 μm.

    Article Snippet: The human bladder carcinoma cell line J82 and the human embryonic kidney cell line HEK293T were purchased from the American Type Culture Collection (ATCC).

    Techniques: Biomarker Discovery, Expressing, Immunohistochemical staining, Staining, Microarray, Western Blot, Transfection, Control, Immunofluorescence

    Effect of curcumin on cell proliferation and mean of IC 50 values of K9TCC-PU AXA ( A ), AXC ( B ), and SH ( C ) canine and human T24 ( D ) cell lines after 72 h of incubation. *** p < 0.001 and **** p < 0.0001. Vertical intermittent lines show IC 50 dose and colored dots represent the drug dose (ng/mL).

    Journal: Animals : an Open Access Journal from MDPI

    Article Title: Antitumor Effect of Curcumin, D6 Turmeric, and Hydrochloride Mitoxantrone on Canine and Human Urothelial Cancer Cells

    doi: 10.3390/ani15111589

    Figure Lengend Snippet: Effect of curcumin on cell proliferation and mean of IC 50 values of K9TCC-PU AXA ( A ), AXC ( B ), and SH ( C ) canine and human T24 ( D ) cell lines after 72 h of incubation. *** p < 0.001 and **** p < 0.0001. Vertical intermittent lines show IC 50 dose and colored dots represent the drug dose (ng/mL).

    Article Snippet: The human T24 bladder carcinoma cell line (ATCC HTB-4TM), donated by Dr. Fernanda Bueno Morrone (Pontifical Catholic University of Rio Grande do Sul, Brazil), originated from a grade III invasive tumor from an 81-year-old female patient [ ].

    Techniques: Incubation

    Effect of D6 turmeric on cell proliferation and mean IC 50 values of K9TCC-PU AXA ( A ), AXC ( B ), and SH ( C ) canine and human T24 ( D ) cell lines after 72 h of incubation. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, and ns = not significant. Vertical intermittent lines show IC 50 dose and colored dots represent the drug dose (µL/mL).

    Journal: Animals : an Open Access Journal from MDPI

    Article Title: Antitumor Effect of Curcumin, D6 Turmeric, and Hydrochloride Mitoxantrone on Canine and Human Urothelial Cancer Cells

    doi: 10.3390/ani15111589

    Figure Lengend Snippet: Effect of D6 turmeric on cell proliferation and mean IC 50 values of K9TCC-PU AXA ( A ), AXC ( B ), and SH ( C ) canine and human T24 ( D ) cell lines after 72 h of incubation. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, and ns = not significant. Vertical intermittent lines show IC 50 dose and colored dots represent the drug dose (µL/mL).

    Article Snippet: The human T24 bladder carcinoma cell line (ATCC HTB-4TM), donated by Dr. Fernanda Bueno Morrone (Pontifical Catholic University of Rio Grande do Sul, Brazil), originated from a grade III invasive tumor from an 81-year-old female patient [ ].

    Techniques: Incubation

    Effect of mitoxantrone hydrochloride on cell proliferation and mean IC 50 values of K9TCC-PU AXA ( A ), AXC ( B ), and SH ( C ) canine and human T24 ( D ) cell lines after 24 h of incubation. ** p < 0.01, *** p < 0.001, and **** p < 0.001. Vertical intermittent lines show IC 50 dose and colored dots represent the drug dose (µM).

    Journal: Animals : an Open Access Journal from MDPI

    Article Title: Antitumor Effect of Curcumin, D6 Turmeric, and Hydrochloride Mitoxantrone on Canine and Human Urothelial Cancer Cells

    doi: 10.3390/ani15111589

    Figure Lengend Snippet: Effect of mitoxantrone hydrochloride on cell proliferation and mean IC 50 values of K9TCC-PU AXA ( A ), AXC ( B ), and SH ( C ) canine and human T24 ( D ) cell lines after 24 h of incubation. ** p < 0.01, *** p < 0.001, and **** p < 0.001. Vertical intermittent lines show IC 50 dose and colored dots represent the drug dose (µM).

    Article Snippet: The human T24 bladder carcinoma cell line (ATCC HTB-4TM), donated by Dr. Fernanda Bueno Morrone (Pontifical Catholic University of Rio Grande do Sul, Brazil), originated from a grade III invasive tumor from an 81-year-old female patient [ ].

    Techniques: Incubation

    Annexin V-FITC/PI after 72 h of incubation with curcumin in canine AXA, AXC, and SH, and human T24 tumor cells. The upper left quadrant (yellow) represents the group of necrotic cells, and the one on the upper right (blue), the group of cells in late apoptosis. The cells in the lower right quadrant (green) represent the group of cells in early apoptosis and the lower left quadrant (pink), the viable cells.

    Journal: Animals : an Open Access Journal from MDPI

    Article Title: Antitumor Effect of Curcumin, D6 Turmeric, and Hydrochloride Mitoxantrone on Canine and Human Urothelial Cancer Cells

    doi: 10.3390/ani15111589

    Figure Lengend Snippet: Annexin V-FITC/PI after 72 h of incubation with curcumin in canine AXA, AXC, and SH, and human T24 tumor cells. The upper left quadrant (yellow) represents the group of necrotic cells, and the one on the upper right (blue), the group of cells in late apoptosis. The cells in the lower right quadrant (green) represent the group of cells in early apoptosis and the lower left quadrant (pink), the viable cells.

    Article Snippet: The human T24 bladder carcinoma cell line (ATCC HTB-4TM), donated by Dr. Fernanda Bueno Morrone (Pontifical Catholic University of Rio Grande do Sul, Brazil), originated from a grade III invasive tumor from an 81-year-old female patient [ ].

    Techniques: Incubation

    The cell migration assay of human urothelial bladder carcinoma cells (T24) treated with curcumin, D6 turmeric, and mitoxantrone hydrochloride and their respective vehicles. The bar graphs represent the mean account of cells in four regions of each well randomly ( left ). The representative microscopy images of the migration assay show T24 cells treated with compounds or vehicles for 24 h, Giemsa, obj 200× ( right ). *** p < 0.001; **** p < 0.0001, and ns = not significant.

    Journal: Animals : an Open Access Journal from MDPI

    Article Title: Antitumor Effect of Curcumin, D6 Turmeric, and Hydrochloride Mitoxantrone on Canine and Human Urothelial Cancer Cells

    doi: 10.3390/ani15111589

    Figure Lengend Snippet: The cell migration assay of human urothelial bladder carcinoma cells (T24) treated with curcumin, D6 turmeric, and mitoxantrone hydrochloride and their respective vehicles. The bar graphs represent the mean account of cells in four regions of each well randomly ( left ). The representative microscopy images of the migration assay show T24 cells treated with compounds or vehicles for 24 h, Giemsa, obj 200× ( right ). *** p < 0.001; **** p < 0.0001, and ns = not significant.

    Article Snippet: The human T24 bladder carcinoma cell line (ATCC HTB-4TM), donated by Dr. Fernanda Bueno Morrone (Pontifical Catholic University of Rio Grande do Sul, Brazil), originated from a grade III invasive tumor from an 81-year-old female patient [ ].

    Techniques: Cell Migration Assay, Microscopy, Migration